Who have Death with Remicade?


Summary

Death is found among people who take Remicade, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Methotrexate, and have Rheumatoid arthritis . We study 119,777 people who have side effects while taking Remicade from FDA and social media. Among them, 1,736 have Death. Find out below who they are, when they have Death and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Remicade

Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from Remicade 120,149 users)

Death

Death has been reported by people with multiple myeloma, primary pulmonary hypertension, diabetes, chronic myeloid leukaemia, multiple sclerosis (latest reports from 343,987 Death patients).

On Nov, 18, 2016

119,777 people reported to have side effects when taking Remicade.
Among them, 1,736 people (1.45%) have Death


Number of reports submitted per year:

Could Remicade cause Death?

Time on Remicade when people have Death *:

  • < 1 month: 25.14 %
  • 1 - 6 months: 13.11 %
  • 6 - 12 months: 17.49 %
  • 1 - 2 years: 10.93 %
  • 2 - 5 years: 16.39 %
  • 5 - 10 years: 15.3 %
  • 10+ years: 1.64 %

Gender of people who have Death when taking Remicade *:

  • female: 56.21 %
  • male: 43.79 %

Age of people who have Death when taking Remicade *:

  • 0-1: 0.12 %
  • 2-9: 1.12 %
  • 10-19: 2.62 %
  • 20-29: 4.0 %
  • 30-39: 6.24 %
  • 40-49: 11.24 %
  • 50-59: 17.6 %
  • 60+: 57.05 %

Severity of Death **:

  • least: 0.0 %
  • moderate: 0.0 %
  • severe: 0.0 %
  • most severe: 100 %

How people recovered from Death **:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Top co-used drugs for these people *:

  • Methotrexate (332 people, 19.12%)
  • Folic Acid (206 people, 11.87%)
  • Prednisolone (121 people, 6.97%)
  • Prednisone (110 people, 6.34%)
  • Fosamax (58 people, 3.34%)

Forecasts by ePatient.care (We will alert you to new symptoms or undetected conditions when you take Remicade, learn more )

Potential co-existing symptoms

  • Pneumonia (120 people, 6.91%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Death when taking Remicade?

Browse all side effects of Remicade

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Death

Death

Could your condition cause Death

Death

Related studies

Can you answer these questions?

More questions for: Remicade, Death

You may be interested in these reviews

More reviews for: Remicade, Death


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.